Table 3.
Cancer categories count and percentage by diagnostic group.
| Cancer category | CN | SMC | MCI | AD | Total |
|---|---|---|---|---|---|
| NMSC | 74 (46.0%) | 19 (48.7%) | 123 (40.6%) | 30 (33.3%) | 246 (41.5%) |
| Prostate | 29 (18.0%) | 4 (10.3%) | 73 (24.1%) | 24 (26.7%) | 130 (21.9%) |
| Breast | 19 (11.8%) | 5 (12.8%) | 25 (8.3%) | 9 (10.0%) | 58 (9.8%) |
| Melanoma | 10 (6.2%) | 5 (12.8%) | 16 (5.3%) | 7 (7.8%) | 38 (6.4%) |
| GI | 9 (5.6%) | 2 (5.1%) | 22 (7.3%) | 4 (4.4%) | 37 (6.2%) |
| Female other | 8 (5.0%) | 1 (2.6%) | 8 (2.6%) | 6 (6.7%) | 23 (3.9%) |
| Glandular | 3 (1.9%) | 2 (5.1%) | 12 (4.0%) | 3 (3.3%) | 20 (3.4%) |
| Bladder | 2 (1.2%) | 1 (2.6%) | 4 (1.3%) | 3 (3.3%) | 10 (1.7%) |
| Renal | 1 (0.6%) | 0 (0.0%) | 4 (1.3%) | 2 (2.2%) | 7 (1.2%) |
| Lymphoma | 2 (1.2%) | 0 (0.0%) | 3 (1.0%) | 1 (1.1%) | 6 (1.0%) |
| Male other | 1 (0.6%) | 0 (0.0%) | 3 (1.0%) | 0 (0.0%) | 4 (0.7%) |
| Oral | 1 (0.6%) | 0 (0.0%) | 3 (1.0%) | 0 (0.0%) | 4 (0.7%) |
| Leukemia | 1 (0.6%) | 0 (0.0%) | 1 (0.3%) | 1 (1.1%) | 5 (0.5%) |
| Other | 1 (0.6%) | 0 (0.0%) | 6 (2.0%) | 0 (0.0%) | 7 (1.2%) |
| Total | 161 (100%) | 39 (100%) | 303 (100%) | 90 (100%) | 593 (100%) |
Values are expressed as count (percentage of cancer category out of total within each diagnostic group). “Other” category consists of cancer types that do not fit within another category; these included one each of the following cancer types: bone, chondrosarcoma, gallbladder, lung, meningioma, liposarcoma, and a foot tumor of unspecified origin. NMSC, non-melanoma skin cancer; GI, gastrointestinal.